Conference: March 14-16
Join global regulators, industry, and academia to engage in a series of strategic discussions on current regulatory landscape, globalization, and harmonization initiatives in Latin America.
DIA brings you a conference with interactive dynamics, where you will be engaged in discussions with key stakeholders influencing the advancement and implementation of regulatory convergence initiatives in Latin America.
Join us to discuss multi-regional cooperation, global harmonization, and best practices related to Latin America’s regulatory landscape. Sessions will highlight regulatory approaches and good practices to ensure reliance in Latin American and strategic initiatives to improve collaboration and cooperation.
*The primary language is English, however simultaneous interpretation in Spanish and Portuguese will be available during this Conference.
Forward-Looking to DIA LARC 2022: Insights from CECEMED and Leveraging Lessons Learned from COVID-19
Thursday, February 10, 2022 | 11:00 – 12:00PM ET
DIA’s Latin America Regulatory Conference (LARC) 2022 virtual Promotional Webinar will provide highlights of the key regulatory concepts and discussions initiatives of theto be discussed at DIA’s LARC 2022 3-day conference occurring held on March 14- to 16, 2022. Gain an insider’s view as to what will be discussed at LARC 2022 with a Sspecial focus will be on Cuba's National Regulatory Authority (NRA), Center for State Control of Medicines, Equipment and Medical Devices (Spanish acronyms CECMED). The Promotional Webinar will touch on lessons learned from the pandemic to achieveing a greater regulatory agility and emergency preparedness in the Latin American region.
Want to learn more about Latin America Regulatory Conference ? You've come to the right site!
Maria Guazzaroni Jacobs, PhD Director, Quality Intelligence, Global Supply
Pfizer Inc, United States
Maria Cristina Mota Pina, MBA Director, Regulatory Policy and Intelligence -Japan, Emerging Markets, Australia
Latin America Federation of Pharmaceutical Industry (FIFARMA), United States
Fernanda Lessa, MBA, MPH Health Regulatory Systems
Viktoria Magyar, LLM, MSc Doctoral Student, Department of Regulatory and Quality Sciences
USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, United States
Roberta Mele Mazza, RPh, RAC Q&RA Manager, División Diagnóstica
Productos Roche , Argentina
Gustavo Mendes Lima Santos, MPharm Herbal and Complementary Medicines Office - GMESP
Brazilian Health Regulatory Agency (ANVISA), Brazil
Maria Antonieta Tony Roman, MPharm Head Regulatory Policy Emerging Markets LATAM
Leonardo Semprun, RPh Global Regulatory Policy Lead-LatAm
Sonia Viejobueno, LLM US and Latin America Policy Lead, Global Regulatory Policy and Intelligence
Johnson & Johnson Innovative Medicine, Argentina
Susan Zavala Coloma, MS, RPh Specialist, Sanitary Evaluation of Pharmaceutical Products, Biological Products
Cammilla Horta Gomes, MA, MPharm LATAM Regulatory Policy Lead
Have an account?